Ergoteles’s Qiagen QGEN Stock Holding History

Ergoteles’s Portfolio QGEN Stock Details QGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-21,372	Closed	-$1.1M	–	1652
2021 Q1	$1.1M	Buy	+21,372	New	+$1.17M	0.03%	353

Other funds holding QGEN

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Ergoteles's QGEN Position: Q2 2021 in Review

Ergoteles sold out of Qiagen (QGEN) in Q2 2021, closing a stake of 21,372 shares — an estimated $1.1M sold.

Ergoteles first reported a position in QGEN in Q1 2021 and held it in 1 quarter. The position peaked at $1.1M in Q1 2021. 257 funds tracked by Wall St. Rank hold QGEN as of Q2 2021.

Ergoteles reported no remaining Qiagen position as of Q2 2021 after selling out during the quarter.
Ergoteles sold 21,372 Qiagen shares in Q2 2021, an estimated $1.1M.
Ergoteles first reported a position in Qiagen in Q1 2021 and held it in 1 quarter.
Ergoteles's Qiagen position peaked at $1.1M in Q1 2021.
257 funds tracked by Wall St. Rank held Qiagen as of Q2 2021.

Based on Ergoteles's 13F filing for Q2 2021, filed 12 Aug 2021.